Search
KALA BIO Inc
KALAAdd to Watchlist
0.781USD
+0.051+7.04%
Close 07-31 16:00（ET）Quotes delayed by 15 min
290.41KMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-30The current earnings forecast score of KALA BIO Inc is 6.00, ranking 330 out of 384 in the Biotechnology & Medical Research industry. The average price target is 1.50, with a high of 1.50 and a low of 1.50.
Analyst Rating
Based on
2
analysts
Hold
Current Rating
1.500
Target Price
+80.07%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
KALA BIO Inc
KALA
2
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is KALA BIO Inc's price target?
Analysts forecast that KALA BIO Inc's price target is USD 1.50, with the highest forecast at USD 1.50 and the lowest forecast at USD 1.50.
How have KALA BIO IncKALA's recent earnings per share performed?
The market expectation was USD -7.00, while KALA BIO IncKALA's earnings per share (EPS) for the previous quarter was USD 0.05. EPS for the next quarter is expected at USD -0.29.
What is the analyst rating for KALA BIO Inc?
Based on the ratings of KALA BIO Inc's stock from 2 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.